Menu
News
Ibogaine
Ketamine
LSD
MDMA
Psilocybin
Resources
Research Hubs
Studies and Reports
Provider Directory
Terminology
Multimedia
Events
About Us
Freedom Biosciences
FDA Approves IND Application for Freedom’s Ketamine-Based Combination Therapy
April
26
,
2024
